Atlas Trials

A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy

Clinical trial NCT03454620 · COMPLETED

Trial details

NCT number
NCT03454620
Sponsor
Green Cross Corporation
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal CancerSolid Tumor
Start date
2018-04-02
Primary completion
2021-09-17
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.